Carmen Bustamante Escobar
Pediatric Endocrinology · Miami, FLNPI 1629483250
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.
Across 128 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$517
- Ascendis Pharma Endocrinology Inc$318
- Sanofi-aventis U.S. LLC$300
- Tandem Diabetes Care, Inc.$267
- Rhythm Pharmaceuticals, Inc.$266
- BETA Bionics, Inc.$245
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,26798%
- Education$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 22 | $517 |
| Ascendis Pharma Endocrinology Inc | 9 | $318 |
| Sanofi-aventis U.S. LLC | 16 | $300 |
| Tandem Diabetes Care, Inc. | 9 | $267 |
| Rhythm Pharmaceuticals, Inc. | 6 | $266 |
| BETA Bionics, Inc. | 8 | $245 |
| Neurocrine Biosciences, Inc. | 2 | $181 |
| AbbVie | 9 | $156 |
| AstraZeneca | 2 | $124 |
| Pfizer | 6 | $122 |
| Azurity Pharmaceuticals, Inc. | 6 | $121 |
| Dexcom, Inc. | 6 | $113 |
| Kyowa Kirin, Inc. | 3 | $71 |
| Abbott | 3 | $66 |
| Lilly USA, LLC | 3 | $63 |
| Tolmar Pharmaceuticals, Inc. | 3 | $57 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Embecta Corp. | 2 | $42 |
| Lifescan, Inc. | 2 | $40 |
| Eton Pharmaceuticals, Inc. | 1 | $37 |
| IBSA Pharma Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $32 |
| Amphastar Pharmaceuticals, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $24 |
| Tolmar, Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iLet Bionic Pancreas$335
- CRENESSITY$154
- Sogroya$122
- SKYTROFA$120
- t:slim X2 Insulin Pump with Control-IQ$117
- Strensiq$105
How this compares
$3,326 in reported general payments places this provider in the 60th percentile of 102 pediatric endocrinology providers in Florida.
Other pediatric endocrinology in Miami
- Alejandro DiazMiami$101K
- Andrea GranadosMiami$19K
- Adriana Carrillo-IreguiMiami$19K
- Janine SanchezMiami$18K
- Joshua TarkoffMiami$9K
- Luis Gonzalez-MendozaMiami$9K
- Omar BeckettMiami$4K
- Pedro Pagan BanchsMiami$4K
- Jonanlis Ramirez AlcantaraMiami$2K
- Marco DanonMiami$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.